Skip to main content
LLY logo

Eli Lilly and Company

LLYNYSEHealthcareDrug Manufacturers - General

$1,288.30Today:- (-)1Y +59.15%

As of Oct 28, 2026 close

Market cap
$1.15T
P/E (TTM)
43.10
Forward P/E
22.66
Dividend yield
0.51%
52-week range
$793.82$1,311.75
Volume (live)
-
Avg. volume (3M)
2.33M

Eli Lilly and Company (LLY) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Eli Lilly and Company generated $16.81B of operating cash flow and spent $10.85B on capital expenditures. That left free cash flow of $5.96B, up 1339.5% from $414.30M a year earlier, or 9.2% of revenue. It returned $9.49B to shareholders through $5.38B in dividends and $4.11B in share buybacks.

Eli Lilly and Company Cash Flow Statement Analysis

Values in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Eli Lilly and Company (LLY) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income20.6410.595.246.245.586.198.323.23-0.20
Depreciation & Amortization2.001.771.531.521.551.321.231.611.57
Deferred Income Tax-1.71-2.68-2.34-2.19-0.80-0.130.060.33-0.79
Stock Based Compensation0.630.650.630.370.340.310.310.280.28
Change in Working Capital-8.09-5.39-3.060.00-1.01-0.75-1.69-2.383.20
Change in Accounts Receivable-7.00-2.16-2.45-0.30-1.28-1.35-0.13-10.76-0.36
Change in Inventory-4.67-2.51-1.43-0.60-0.24-0.53-0.260.01-0.25
Change in Accounts Payable10.192.614.271.33-1.011.27-0.48-0.280.92
Change in Other Working Capital3.53-3.33-3.45-0.431.52-0.14-0.828.662.90
Other Operating Activities3.533.882.241.631.71-0.44-3.402.461.55
Net Cash from Operating Activities16.818.824.247.597.376.504.845.525.62
Investing Activities
Capital Expenditures-10.85-8.40-7.39-2.99-1.98-2.03-1.35-3.02-2.16
Acquisitions-0.66-0.95-1.04-0.33-0.75-0.85-6.940.00-0.88
Purchases of Investments-0.65-0.78-0.83-0.71-1.01-0.37-0.29-0.95-8.00
Sales/Maturities of Investments0.960.520.700.460.850.890.756.067.44
Other Investing Activities0.00-3.04-2.53-1.34-0.640.10-0.25-2.00-0.18
Net Cash from Investing Activities-10.97-9.30-7.15-3.76-2.87-2.26-8.081.91-3.78
Financing Activities
Debt Repayment-0.788.908.65-0.060.500.294.69-0.733.00
Common Stock Issued0.000.000.000.000.000.000.001.660.00
Common Stock Repurchased-4.11-2.50-0.75-1.50-1.25-0.50-4.40-4.15-0.30
Dividends Paid-5.38-4.68-4.07-3.54-3.09-2.69-2.41-2.31-2.19
Other Financing Activities-0.77-0.49-0.34-0.31-0.30-0.24-0.20-0.37-0.36
Net Cash from Financing Activities-2.211.233.50-5.41-4.13-3.14-2.32-5.900.14
Summary
Effect of Forex Changes on Cash0.37-0.300.17-0.17-0.210.22-0.09-0.06-0.02
Net Change in Cash4.000.450.75-1.750.161.32-5.661.461.95
Cash at Beginning of Period3.272.822.073.823.662.348.006.544.58
Cash at End of Period7.273.272.822.073.823.662.348.006.54
Free Cash Flow5.960.41-3.154.605.394.473.482.513.45
Supplemental Disclosures
Interest Paid0.630.580.400.320.34----
Income Taxes Paid10.816.565.562.671.60----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Eli Lilly and Company Cash Flow

What is Eli Lilly and Company's free cash flow?

Eli Lilly and Company generated free cash flow of $5.96B in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $16.81B minus $10.85B of capital expenditures. That was up 1339.5% from $414.30M a year earlier. Free cash flow equaled 9.2% of revenue.

How much does Eli Lilly and Company spend on capital expenditures?

Eli Lilly and Company spent $10.85B on capital expenditures in fiscal 2025, compared with $8.40B a year earlier. That equals 64.5% of operating cash flow.

Does Eli Lilly and Company pay dividends or buy back shares?

Yes. In fiscal 2025 Eli Lilly and Company returned $5.38B in dividends and $4.11B in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition